Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

10355	Companies
215502	Keywords
145322	Articles
114166	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 12/17/2024 at 18:00, 1 year 4 months ago

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS
Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions

License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF

published on 11/19/2024 at 18:05, 1 year 5 months ago

Theranexus présente des résultats positifs pour le traitement de la maladie de Batten CLN3

Essai Clinique Theranexus Batten-1 Maladie De Batten Acuité Visuelle
BRIEF

published on 11/19/2024 at 18:05, 1 year 5 months ago

Theranexus presents positive results for the treatment of Batten disease CLN3

Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 5 months ago

Theranexus fait le point sur son programme Batten-1 dans la maladie de Batten CLN3
Présentation des résultats prometteurs de l'essai de phase I/II de Batten-1 par Theranexus et BBDF lors du Child Neurology Society Annual Meeting. Signaux positifs sur l'acuité visuelle de patients atteints de CLN3

Essai Clinique Theranexus Maladie De Batten CLN3 BBDF Acuité Visuelle
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 5 months ago

Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization

Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF

published on 10/23/2024 at 18:05, 1 year 6 months ago

Theranexus Annonce Sa Trésorerie au 30 Septembre 2024

Trésorerie Maladie De Batten Partenariats Industriels Miglustat Crédit Impôt Recherche
BRIEF

published on 10/23/2024 at 18:05, 1 year 6 months ago

Theranexus Announces Its Cash Position as of September 30, 2024

Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 6 months ago

THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2024
Theranexus annonce sa trésorerie au 30 septembre 2024 avec 1,9 M€ disponible, incluant le Crédit Impôt Recherche de 785 K€. Projet d'enregistrement en Europe et phase 3 dans la maladie de Batten

Trésorerie Phase 3 Theranexus Maladies Neurologiques CIR
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 6 months ago

THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024
Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases

Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
BRIEF

published on 10/17/2024 at 18:05, 1 year 6 months ago

Theranexus s'associe à Synerlab pour une avancée dans le traitement de Niemann-Pick C

Theranexus EMA Synerlab Miglustat Niemann-Pick C

Accesswire

Published on 05/07/2026 at 02:00, 1 hour 34 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 4 hours 4 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 4 hours 29 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 4 hours 34 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 5 hours 24 minutes ago

Banyan Gold Announces Closing of $46.5 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 00:47, 2 hours 46 minutes ago

Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 2 hours 50 minutes ago

EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 7 hours 1 minute ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 7 hours 11 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 8 hours 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/06/2026 at 18:00, 9 hours 33 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 9 hours 33 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 9 hours 34 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 9 hours 34 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 9 hours 49 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE